News Conference News AHA 2025 Metformin Before Catheter Ablation for AF Helps Nondiabetic Patients With Overweight Caitlin E. Cox November 18, 2025
News Daily News PRAGUE-25: Ablation Improves Rhythm Control, but Don’t Discount Lifestyle Changes Todd Neale July 14, 2025
News Conference News HRS 2025 GLP-1 Drugs May Have Role in Secondary Prevention of AF Todd Neale April 28, 2025
News Conference News AHA 2024 Lifestyle and Risk Factors Matter for AF Burden—Metformin May Not: TRIM-AF Shelley Wood November 18, 2024
News Daily News Lower-Dose Edoxaban May Be an Option After Age 80: ENGAGE AF-TIMI 48 Analysis Todd Neale July 12, 2024
News Daily News BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes Todd Neale February 02, 2024
News Daily News New AF Guideline Emphasizes Early Rhythm Control, Elevates Ablation and LAAO Todd Neale November 30, 2023
News Conference News AHA 2023 Off-label DOAC Dosing Common in Hospitalized AF Patients, Too Todd Neale November 07, 2023
News Daily News Subclinical HFpEF Common in Patients Undergoing AF Ablation Todd Neale September 08, 2023
News Features Skyrocketing Popularity Puts GLP-1 Agonists for Weight Loss on Cardiology’s Radar L.A. McKeown May 12, 2023
News Daily News VITAL Rhythm Data May Flip the Script on AF Screening in Women L.A. McKeown September 08, 2022
News Daily News Postoperative AF ‘Not Benign,’ Just As Likely to Cause Stroke Yael L. Maxwell July 29, 2022
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News EHRA 2021 EHRA Updates Its Popular ‘Practical’ NOAC Guide Todd Neale April 29, 2021
News Daily News Belly Fat the Biggest Driver of Obesity-Related CVD, Says AHA Michael O'Riordan April 26, 2021
News Conference News EHRA 2021 RACE 3: Effects Wane for Targeted Therapy in Early AF, HF Todd Neale April 26, 2021
News Daily News Lower Dose of Edoxaban Supported in ENGAGE-AF-TIMI 48 Analysis Todd Neale March 02, 2021